Skip to main content

Get the latest public health information from CDC

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinicalinfo.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Guidance for Covid-19 and People with HIV is now available.

See Guidance 

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

Mobile Application

Mobile App Information 
Our website, Clinicalinfo.HIV.gov, is now optimized for mobile browsing. Therefore, the Clinicalinfo mobile application will sunset on December 30, 2022.


 

 

Entry and Attachment Inhibitors

  • Read more about Entry and Attachment Inhibitors

Protease Inhibitors

  • Read more about Protease Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

  • Read more about Non-Nucleoside Reverse Transcriptase Inhibitors

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

  • Read more about Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Overview

  • Read more about Overview

Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy

  • Read more about Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy

Pregnant People Who Have Not Achieved Viral Suppression on Antiretroviral Therapy

  • Read more about Pregnant People Who Have Not Achieved Viral Suppression on Antiretroviral Therapy

Antiretroviral Drug Resistance and Resistance Testing in Pregnancy

  • Read more about Antiretroviral Drug Resistance and Resistance Testing in Pregnancy

Monitoring During Pregnancy

  • Read more about Monitoring During Pregnancy

Recommendations for Use of Antiretroviral Drugs During Pregnancy

  • Read more about Recommendations for Use of Antiretroviral Drugs During Pregnancy

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

CONNECT WITH US

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.